206
Views
50
CrossRef citations to date
0
Altmetric
Original Research

Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior

, , , , , , , & show all
Pages 2805-2814 | Published online: 07 Apr 2015

References

  • MyasoedovaECynthiaSCHilalMTerryMTSherineEGIs the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007Arthritis Rheum2010621576158220191579
  • SanchezCMathy-HartertMDebergMAFicheuxHReginsterJYHenrotinYEEffects of rhein on human articular chondrocytes in alginate beadsBiochem Pharmacol20036537738812527330
  • Alvarez-SoriaMAHerrero-BeaumontGSanchez-PernauteOBellidoMLargoRDCN has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast – comparison to its effects on osteoarthritic chondrocytesRheumatology20084762763318375401
  • MaskiNKumaranAGirhepunjeKGhodePRandiveSPalRStudies on the preparation, characterization and solubility of β-cyclodextrin-DCN inclusion complexesInt J Pharm Pharm Sci20091121135
  • NicolasPTodMPadoinCPetitjeanOClinical pharmacokinetics of diacereinClin Pharmacokinet1998353473599839088
  • DougadosMNguyenMBerdahLMaziéresBVignonELequesneMECHODIAH Investigators Study GroupEvaluation of the structure-modifying effects of DCN in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the chondromodulating effect of diacerein in OA of the hipArthritis Rheum2001442539254711710710
  • BrahmachariBChatterjeeSGhoshAEfficacy and safety of DCN in early knee osteoarthritis: a randomized placebo-controlled trialClin Rheumatol200981193119819597913
  • European Medicine AgencyPRAC recommends suspension of diacerein-containing medicinesLondon, UKEuropean Medicine Agency Online Resources, Inc2013 Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001947.jsp&mid=WC0b01ac058004d5c1Accessed November 10, 2013
  • Ramos-ZavalaMGGonzález-OrtizMMartínez-AbundisERobles-CervantesJAGonzález-LópezRSantiago-HernándezNJEffect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trialDiabetes Care2011341591159421610123
  • MehnertWMäderKSolid lipid nanoparticles. Production, characterization and applicationsAdv Drug Deliv Rev20014716519611311991
  • KhalilRMEl-BaryAAKassemMAGhorabMMAhmedMBSolid lipid nanoparticles for topical delivery of meloxicam: development and in vitro characterizationPresented at the Annual International Interdisciplinary ConferenceApril 24–26, 2013Azores Islands, Portugal
  • MühlenASchwarzCMehnertWSolid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanismEur J Pharm Biopharm1998451491559704911
  • JohDYKaoGDMurtySTheranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumorsTransl Oncol2013672273124466375
  • HussainIHussainSZHabib-ur-RehmanIn situ growth of gold nanoparticles on latent fingerprints – from forensic applications to inkjet printed nanoparticle patternsNanoscale201022575257820959933
  • JenningVMäderKGohlaSHSolid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: a 1H-NMR studyInt J Pharm2005205152111000538
  • Research Unit of General Practice, CopenhagenImplantation of gold beads to relieve discomfort from knee osteoarthritisBethesda, MD, USANational Institutes of Health2007 Available from: http://clinicaltrials.gov/show/NCT00487370Accessed November 23, 2014
  • RothenfluhDABermudezHO’NeilCPHubbellJABiofunctional polymer nanoparticles for intraarticular targeting and retention in cartilageNat Mater2008724825418246072
  • YeoYBaekNParkKMicroencapsulation methods for delivery of protein drugsBiotechnol Bioprocess Eng20016213230
  • MaoSRWangYZJiHYBiDZPreparation of solid lipid nanoparticles by microemulsion techniqueYao Xue Xue Bao200338624626 Chinese14628457
  • KumarPPGayatriPSunilRJaganmohanSRaoYMAtorvastatin loaded solid lipid nanoparticles: formulation, optimization, and in vitro characterizationIOSR J Pharm201322332
  • ChavdaHPatelJChavadaGDaveSPatelAPatelCSelf- nanoemulsifying powder of isotretinoin: preparation and characterizationJ Powder Technol20132013108569
  • ClogstonJDPatriAKZeta potential measurementMethods Mol Biol2011697637021116954
  • JainAKumarSSYuvrajSSanjaySDevelopment of lipid nanoparticles of DCN, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effectsJ Biomed Nanotechnol2013989190023802421
  • AkbariBTavandashtiMPZandrahimiMParticle size characterization of nanoparticles – a practical approachIran J Mater Sci Eng201184856
  • MullerRHMaderKGohlaSSolid lipid nanoparticle (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm20005016117710840199
  • LobovkinaTJacobsonGBGonzalezEGIn vivo sustained release of siRNA from solid lipid nanoparticlesACS Nano201159977998322077198
  • FriedrichIReichlSMüller-GoymannCCDrug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS)Int J Pharm200530516717516242276
  • CollinsJACoshJATemperature and biochemical studies of joint inflammationAnn Rheum Dis1970293863894916768
  • McAlindonTFormicaMSchmidCHFletcherJChanges in barometric pressure and ambient temperature influence osteoarthritis painAm J Med200712042943417466654
  • RobinsonVBrosseauLCasimiroLThermotherapy for treating rheumatoid arthritisCochrane Database Syst Rev20022CD00282612076454
  • Barzegar-JalaliMAdibkiaKValizadehHKinetic analysis of drug release from nanoparticlesJ Pharm Pharm Sci20081116717718471378